ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 120

Patients with Rheumatoid Arthritis Have Higher Lifetime Professional and Non-Professional Exposure to Silica Dust Particles Compared to General Population

Luca Semerano1,2,3, Catherine Cavalin4,5,6, Odile Macchi4,7, Sara El Rharras3, Mylene Petit3, Patrice Decker8,9, Emma Andre10, Paul André Rosental4,11 and Marie-Christophe Boissier12, 1UMR 1125, Inserm, Bobigny, France, 2EA4222, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 3Service de Rhumatologie, Assistance Publique – Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne - Jean Verdier – René Muret, Bobigny, France, 4SILICOSIS project, ERC Advanced Grant, Centre for European Studies, Sciences Po, Paris, France, 5Centre for Employment and Labour Studies (CNAM), Noisy-le-Grand, France, 6Laboratory for Interdisciplinary Evaluation of Public Policies (LIEPP, Sciences Po, Paris), Paris, France, 7Centre for Historical Research, CNRS-EHESS, Paris, France, 8Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 9UMR 1125, INSERM, Bobigny, France, 10UMR1125, Inserm, Bobigny, France, 11National Institute for Demographic Studies (INED), Paris, France, 1274 rue Marcel Cachin, INSERM, Bobigny, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: environmental factors and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Occupational exposure to silica dust has been associated with increased risk of developing ACPA positive Rheumatoid arthritis (RA)1,2,3. Little is known about non-occupational exposure, as there are no available tools to assess it in clinical practice.

The Dust Exposure Life-Course Questionnaire (DELCQ) longitudinally quantifies lifetime occupational and non-occupational (e.g. body care; hobbies such as DIY, woodworking, stone cutting etc.. ).

The DELCQ, developed within a European Research Council Advanced Grant, provides clinical research with a tool derived from social sciences .In the DELCQ, the identification of situations likely to put people at risk of exposure is grounded on an extensive list of products and activities summed up by the International Agency on Research on Cancer IARC4 and on a wide overview of the literature that in medicine, epidemiology and industrial hygiene has been addressing silica exposure and silica-related (or suspected-to-be-related) diseases.

The aim of this study was to use this novel tool to explore occupational and non-occupational silica exposure in a series of consecutive RA patients and to explore the association of quantified silica dust exposure with major disease features (ACPA positivity) or outcomes (erosive disease).

Methods:

The DELCQ was administered to 97 consecutive RA patients (77F, 20M, mean age 59.1+/- 13.3 yrs.,75 ACPA positives, 66 with erosive disease) attending the department of rheumatology of the Avicenne teaching Hospital (Bobigny, FRANCE).The DELQQC scores of patients were compared to those of 261 controls, matched for sex, age and smoking status, from a 825-subject national cohort, representative of the general French population (ELIPSSilice). Within RA subjects, the association of the scores with ACPA positivity and with erosive disease was assessed after adjustment for tobacco exposure.

Results:

RA patients had higher scores of total (median [Q1, Q3]: 25 [13, 36] vs. 9 [4, 19]), occupational (10 [0, 17] vs. 0 [0, 4]) and non-occupational (15 [8, 20] vs. 7 [0, 15]) exposure vs. controls (p<0.0001 for all comparisons). Amongst RA patients, male vs. female patients had higher occupational scores of exposure (12 [2, 18] vs. 0 [0, 3] p<0.005), while non-occupational exposure was not significantly different (12 [3, 25] vs. 8[4, 15]). After adjusting for smoking (ever smokers vs. nonsmokers), neither professional of non-professional scores were associated with erosive disease, despite a strong negative interaction with tobacco exposure.

Conclusion:

By using a tool developed in collaboration of social sciences, this work shows for the first time that RA patients have higher nonprofessional lifetime exposure to silica dust compared to age and sex-matched subjects from the general population. Moreover, higher occupation exposure in RA is confirmed, in accordance with previous literature. Neither occupational nor non-occupational exposure was associated with ACPA positivity or erosive disease, likely due to the high prevalence of ACPA positivity and severe disease in the patient series.


Disclosure: L. Semerano, None; C. Cavalin, None; O. Macchi, None; S. El Rharras, None; M. Petit, None; P. Decker, None; E. Andre, None; P. A. Rosental, None; M. C. Boissier, None.

To cite this abstract in AMA style:

Semerano L, Cavalin C, Macchi O, El Rharras S, Petit M, Decker P, Andre E, Rosental PA, Boissier MC. Patients with Rheumatoid Arthritis Have Higher Lifetime Professional and Non-Professional Exposure to Silica Dust Particles Compared to General Population [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-have-higher-lifetime-professional-and-non-professional-exposure-to-silica-dust-particles-compared-to-general-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-have-higher-lifetime-professional-and-non-professional-exposure-to-silica-dust-particles-compared-to-general-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology